Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference29 articles.
1. AmpC β-lactamase-producing Enterobacterales: what a clinician should know;Meini;Infection,2019
2. Resistance in Gram-negative bacteria: Enterobacteriaceae;Paterson;Am J Infect Control,2006
3. Antibacterial Resistance Leadership Group. A primer on AmpC β-lactamases: necessary knowledge for an increasingly multidrug-resistant world;Tamma;Clin Infect Dis,2019
4. Interplay between β-lactamases and new β-lactamase inhibitors;Bush;Nat Rev Microbiol,2019
5. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae;Tamma;Clin Infect Dis,2013
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The impact of meropenem shortage and post-prescription review and feedback on broad-spectrum antimicrobial use: An interrupted time-series analysis;Infection Prevention in Practice;2024-09
2. Evaluation of the quickmic system in the rapid diagnosis of Gram-negative bacilli bacteremia;Microbiology Spectrum;2024-08-28
3. Treatment of multidrug-resistant Gram-negative bloodstream infections in critically ill patients: an update;Current Opinion in Critical Care;2024-07-08
4. Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing;Clinical Infectious Diseases;2024-06-21
5. Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): Epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020–2022;International Journal of Antimicrobial Agents;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3